News / CLS

California Life Sciences Announces Fall 2026 FAST California Cohort

FAST Startups

SOUTH SAN FRANCISCO, Calif., September 10, 2026 — California Life Sciences (CLS) today announced that 11 companies have been accepted into the Fall 2026 cohort of FAST California, the association’s flagship innovation and entrepreneurship program.

The Fall 2026 cohort spans cell therapy, drug discovery, rare disease, medical devices, and neuroscience, reflecting the depth and diversity of innovation advancing across California’s life sciences ecosystem.

  • Chimera Therapeutics
  • Ditto Bio
  • Eye Guardian Device Corp
  • Forta Bio, Inc.
  • Lucina Biotherapeutics
  • ResNovas Therapeutics
  • Selene Nanorobotics, Inc.
  • Therapeutics Pharma
  • Therna Biosciences
  • Third Element Bio
  • TLR Biosciences, Inc.

FAST California provides founders of disruptive innovative life science technology companies with a customized advisory program to develop a strong business model and go-to-market strategy, provide guidance on pre-clinical development, regulatory pathway, and provide insights into pharma partnerships, licensing, and exit strategies.

A group of curated advisors, each with deep domain expertise, will work with them over twelve weeks to build a compelling commercialization strategy and prepare them to pitch to potential investors and collaboration partners. The program concludes with the Innovation Showcase which provides a unique opportunity to network with industry leaders, investors, and KOLs.

To learn more about the Fall cohort, visit https://www.califesciences.org/insights/CLS-FAST-fall-2026/

About California Life Sciences: California Life Sciences (CLS) is the state’s leading advocate for the life sciences. We represent the entire innovation ecosystem, from startups and global companies to research institutions and service providers. We champion smart policy, foster strategic connections, and deliver resources that help life sciences companies grow and thrive. Based in the global epicenter of innovation, we work to ensure that the discoveries made here translate into healthier lives everywhere.

###

For media inquiries, please contact:

Katie Kiss
Senior Director, Marketing
(858) 456-8894
[email protected]